Benefitfocus, Inc.

2022 Q1 Form 10-Q Financial Statement

#000156459022018289 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.97M $188.9M
YoY Change -68.78% 64.66%
Cash & Equivalents $58.97M $94.05M
Short-Term Investments $0.00 $94.82M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $49.26M $45.30M
Other Receivables $0.00 $0.00
Total Short-Term Assets $108.2M $234.1M
YoY Change -53.77% 38.19%
LONG-TERM ASSETS
Property, Plant & Equipment $80.71M $95.40M
YoY Change -15.4% -12.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $143.1M $127.6M
YoY Change 12.14% -11.51%
TOTAL ASSETS
Total Short-Term Assets $108.2M $234.1M
Total Long-Term Assets $143.1M $127.6M
Total Assets $251.3M $361.7M
YoY Change -30.52% 15.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.466M $6.600M
YoY Change -2.03% 4.76%
Accrued Expenses $31.38M $25.90M
YoY Change 21.14% -17.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $66.12M $60.70M
YoY Change 8.92% -10.07%
LONG-TERM LIABILITIES
Long-Term Debt $119.8M $187.2M
YoY Change -36.02% -6.82%
Other Long-Term Liabilities $77.54M $85.20M
YoY Change -8.99% 125194.12%
Total Long-Term Liabilities $197.3M $272.4M
YoY Change -27.56% 400488.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.12M $60.70M
Total Long-Term Liabilities $197.3M $272.4M
Total Liabilities $263.4M $333.1M
YoY Change -20.91% -6.46%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$91.31M -$50.61M
YoY Change
Total Liabilities & Shareholders Equity $251.3M $361.7M
YoY Change -30.52% 15.33%

Cashflow Statement

Concept 2022 Q1 2021 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58972000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31001000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
112156000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
675000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
675000
CY2022Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5000000
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5000000
CY2022Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1777778
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1777778
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1777778
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1777778
CY2022Q1 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
45
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000
CY2021Q4 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
45
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
79193000
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
79193000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2097000
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1600000
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1600000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3877000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3697000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10832000
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
1006000
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
1400000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-37000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
12000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
57000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33521117
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33521117
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33460545
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33460545
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2277000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2097000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33496846
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32490811
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-76317000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1189000
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1600000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-48595000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
155000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1523000
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1600000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2097000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-50614000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-2277000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-2097000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6737000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6353000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1189000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1523000
CY2022Q1 bnft Accretion Of Interest On Convertible Senior Notes
AccretionOfInterestOnConvertibleSeniorNotes
188000
CY2021Q1 bnft Accretion Of Interest On Convertible Senior Notes
AccretionOfInterestOnConvertibleSeniorNotes
2868000
CY2022Q1 bnft Non Cash Accrued Finance Lease Interest Expense
NonCashAccruedFinanceLeaseInterestExpense
17000
CY2021Q1 bnft Non Cash Accrued Finance Lease Interest Expense
NonCashAccruedFinanceLeaseInterestExpense
1879000
CY2022Q1 bnft Rent Expense Less Than Payments
RentExpenseLessThanPayments
-27000
CY2021Q1 bnft Rent Expense Less Than Payments
RentExpenseLessThanPayments
-13000
CY2022Q1 bnft Non Cash Accretion Income From Investments
NonCashAccretionIncomeFromInvestments
-29000
CY2021Q1 bnft Non Cash Accretion Income From Investments
NonCashAccretionIncomeFromInvestments
-227000
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0
CY2021Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-45000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7014000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2256000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-284000
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
136000
CY2022Q1 bnft Increase Decrease In Contract Prepaid And Other Current Assets
IncreaseDecreaseInContractPrepaidAndOtherCurrentAssets
-1859000
CY2021Q1 bnft Increase Decrease In Contract Prepaid And Other Current Assets
IncreaseDecreaseInContractPrepaidAndOtherCurrentAssets
-463000
CY2022Q1 bnft Increase Decrease In Deferred Costs And Other Non Current Assets
IncreaseDecreaseInDeferredCostsAndOtherNonCurrentAssets
-789000
CY2021Q1 bnft Increase Decrease In Deferred Costs And Other Non Current Assets
IncreaseDecreaseInDeferredCostsAndOtherNonCurrentAssets
-823000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4899000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5835000
CY2022Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-141000
CY2021Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-7208000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
266000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
426000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
32000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3000000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8764000
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
22329000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
22045000
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
14691000
CY2021Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1748000
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2430000
CY2021Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2162000
CY2022Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
15518000
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
16292000
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
500000
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2010000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1893000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
34226000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1722000
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1600000
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1600000
CY2022Q1 bnft Change In Amounts Payable On Behalf Of Customer Members
ChangeInAmountsPayableOnBehalfOfCustomerMembers
1151000
CY2021Q1 bnft Change In Amounts Payable On Behalf Of Customer Members
ChangeInAmountsPayableOnBehalfOfCustomerMembers
0
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
155000
CY2022Q1 bnft Payments On Financing Obligations
PaymentsOnFinancingObligations
0
CY2021Q1 bnft Payments On Financing Obligations
PaymentsOnFinancingObligations
223000
CY2022Q1 bnft Payments Of Principle On Financing Lease Obligations
PaymentsOfPrincipleOnFinancingLeaseObligations
2806000
CY2021Q1 bnft Payments Of Principle On Financing Lease Obligations
PaymentsOfPrincipleOnFinancingLeaseObligations
2034000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3255000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3702000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27971000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3340000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31001000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90706000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58972000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94046000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
31000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
88000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:9pt;font-family:Arial;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Such estimates include allowances for credit losses and returns, valuations of deferred income taxes, long-lived assets, capitalizable software development costs and the related amortization, contingent consideration, incremental borrowing rate used in lease accounting, the determination of the useful lives of assets, and the impairment assessment of acquired intangibles and goodwill. Additionally, as described in revenue and deferred revenue below, estimates are utilized in association with revenue recognition, in particular the estimation of variable consideration using the expected value method from insurance broker commissions reported in Platform revenue. Determination of these transactions and account balances are based on, among other things, the Company’s estimates and judgments. These estimates are based on the Company’s knowledge of current events and actions it may undertake in the future as well as on various other assumptions that it believes to be reasonable. Actual results could differ materially from these estimates.</p>
CY2022Q1 bnft Contract Cost Payment Term Description
ContractCostPaymentTermDescription
The Company capitalizes costs to obtain contracts that are considered incremental and recoverable, such as sales commissions.  Payments of sales commissions generally include multiple payments. The Company capitalizes only those payments made within an insignificant time from the contract inception, typically three months or less.  Subsequent payments are expensed as incurred. The capitalized costs are amortized to sales and marketing expense over the estimated period of benefit of the asset, which is generally four to five years. The Company expenses the costs to obtain a contract when the amortization period is less than one year.
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1151000
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1151000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:9pt;font-family:Arial;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash equivalents, marketable securities and accounts receivable. All of the Company’s cash, cash equivalents and restricted cash are held at financial institutions that management believes to be of high credit quality. The bank deposits of the Company might, at times, exceed federally insured limits and are generally uninsured and uncollateralized. The Company has not experienced any losses on cash, cash equivalents and restricted cash to date.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:9pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To manage accounts receivable risk, the Company evaluates the creditworthiness of its customers and maintains an allowance for doubtful accounts. Accounts receivable are unsecured and derived from revenue earned from customers located in the United States. One customer represented approximately 11% of accounts receivable as of <span style="color:#000000;">March 31, 2022</span>. No customer exceeded 10% of accounts receivable as of December 31, 2021. No customer exceeded 10% of total revenue in any of the three-month periods ended March 31, 2022 and 2021.</p>
CY2022Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1656000
CY2021Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
0
CY2021Q4 bnft Available For Sale Securities Debt Securities Net Carrying Amount
AvailableForSaleSecuritiesDebtSecuritiesNetCarryingAmount
37049000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10628817
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11723330
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2277000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2097000
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1600000
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1600000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3877000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3697000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33496846
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32490811
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
0
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
37049000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
37049000
CY2022Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
26600000
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
18970000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
133000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
167000
CY2022Q1 bnft Accounts For Returns
AccountsForReturns
2963000
CY2021Q4 bnft Accounts For Returns
AccountsForReturns
2312000
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
23504000
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
16491000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
167000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
200000
CY2022Q1 us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
0
CY2021Q1 us-gaap Accounts Receivable Change In Method Credit Loss Expense Reversal
AccountsReceivableChangeInMethodCreditLossExpenseReversal
48000
CY2022Q1 bnft Allowance For Doubtful Accounts Receivable Write Offs And Recoveries
AllowanceForDoubtfulAccountsReceivableWriteOffsAndRecoveries
34000
CY2021Q1 bnft Allowance For Doubtful Accounts Receivable Write Offs And Recoveries
AllowanceForDoubtfulAccountsReceivableWriteOffsAndRecoveries
0
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
133000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
248000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2806000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2034000
CY2022Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1849000
CY2021Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
102000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
121000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
122000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
45
CY2020Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.0800
CY2020Q2 bnft Preferred Stock Redemption Percent Of Stated Value
PreferredStockRedemptionPercentOfStatedValue
1.05
CY2020Q2 bnft Shares Will Beneficially Own In Excess Of Shares Of Common Stock Outstanding
SharesWillBeneficiallyOwnInExcessOfSharesOfCommonStockOutstanding
0.199
CY2020Q2 bnft Common Stock Shares Outstanding Ownership Percentage
CommonStockSharesOutstandingOwnershipPercentage
0.199
CY2020Q2 bnft Percentage Of Hold Shares Of Preferred Stock Originally Purchased
PercentageOfHoldSharesOfPreferredStockOriginallyPurchased
0.10
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10822421
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
96500
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2919085
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10822421
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61225000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65063000
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
18051000
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
15191000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30133000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
30399000
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
15105000
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12311000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32204000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
32630000
CY2021Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
0
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14200000
CY2022Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
250000000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2022Q1 bnft Percentage Taxable Income On Utilization Of Net Operating Loss In Indefinite Life Period Tax Cuts And Jobs Act Of2017
PercentageTaxableIncomeOnUtilizationOfNetOperatingLossInIndefiniteLifePeriodTaxCutsAndJobsActOf2017
0.80
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001564590-22-018289-index-headers.html Edgar Link pending
0001564590-22-018289-index.html Edgar Link pending
0001564590-22-018289.txt Edgar Link pending
0001564590-22-018289-xbrl.zip Edgar Link pending
bnft-10q_20220331.htm Edgar Link pending
bnft-10q_20220331_htm.xml Edgar Link completed
bnft-20220331.xsd Edgar Link pending
bnft-20220331_cal.xml Edgar Link unprocessable
bnft-20220331_def.xml Edgar Link unprocessable
bnft-20220331_lab.xml Edgar Link unprocessable
bnft-20220331_pre.xml Edgar Link unprocessable
bnft-ex311_6.htm Edgar Link pending
bnft-ex312_8.htm Edgar Link pending
bnft-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending